LETTER
Asymmetric Synthesis of Oxa-spirocyclic Indanones
147
8.01–7.94 (m, 2 H), 7.40–7.34 (m, 3 H), 7.27–7.26 (m, 2 H), 5.64
(d, J = 12.4 Hz, 1 H), 4.16 (t, J = 12.0 Hz, 1 H), 3.10–3.02 (m, 1 H),
1.39 (d, J = 6.8 Hz, 3 H). 13C NMR (100 MHz, CDCl3): δ = 192.31,
190.03, 169.62, 141.15, 140.18, 138.00, 137.48, 135.43, 129.51,
129.05, 127.77, 124.99, 124.72, 87.28, 46.58, 41.42, 14.74. HRMS
(ESI): calcd for C20H15NO6+Na: 388.0797; found: 388.0795.
Runsink, J.; Raabe, G.; Wendt, B. Angew. Chem. Int. Ed.
2007, 46, 467.
(11) (a) Han, B.; Xiao, Y.-C.; He, Z.-Q.; Chen, Y.-C. Org. Lett.
2009, 11, 4660. (b) Wang, Y.; Yu, D.-F.; Liu, Y.-Z.; Wei,
H.; Luo, Y.-C.; Dixon, D. J.; Xu, P.-F. Chem. Eur. J. 2010,
16, 3922.
(12) (a) Hayashi, Y.; Okano, T.; Aratake, S.; Hazelard, D.
Angew. Chem. Int. Ed. 2007, 46, 4922. (b) Uehara, H.;
Imashiro, R.; Hermandez-Torres, G.; Barbas, C. F. III. Proc.
Natl. Acad. Sci. U.S.A. 2010, 107, 20672. (c) Ishikawa, H.;
Sawano, S.; Yasui, Y.; Shibata, Y.; Hayashi, Y. Angew.
Chem. Int. Ed. 2011, 50, 3774.
(13) (a) Wu, G.; Ouyang, L.; Liu, J.; Zeng, S.; Huang, W.; Han,
B.; Wu, F.; He, G.; Xiang, M. Mol. Diversity 2013, 17, 271.
(b) Huang, J.-R.; Dong, L.; Han, B.; Peng, C.; Chen, Y.-C.
Chem. Eur. J. 2012, 18, 8896. (c) Dong, L.; Huang, J.-R.;
Qu, C.; Zhang, Q.; Zhang, W.; Han, B.; Peng, C. Org.
Biomol. Chem. 2013, 11, 6142.
Acknowledgment
This work was supported by the Specialized Research Fund for the
Doctoral Program of Higher Education (20125132120005), the Ap-
plication Foundation of the Science and Technology Department of
Sichuan Province (2011JZY037), and the National Science Founda-
tion of China (81303208).
Supporting Information for this article is available online at
m
iotSrat
ungIifoop
r
t
(14) Compounds 7a–m; General Procedure
The reaction was carried out with aldehyde 1 (0.4 mmol) and
nitroolefin 2 (0.3 mmol) in the presence of catalyst 3a (0.04
mmol) and AcOH (0.04 mmol) in toluene (2.0 mL) at r.t. for
3 h to afford the Michael adduct 4. When the reaction was
complete, a solution of ninhydrin (5) (0.2 mmol) and DBU
(0.6 mmol) in toluene (2.0 mL) was added. The mixture was
stirred at r.t. for the requisite amount of time until the
reaction was complete (monitored by TLC). The mixture
was concentrated and the residue purified by flash
chromatography on silica gel (PE–EtOAc, 10:1) to give
hemiacetal 6. To a solution of 6 in CH2Cl2 (2 mL) was added
PCC (0.5 mmol) and the mixture stirred for 2 h at 50 °C. The
solid was removed by filtration through Celite. The filtrate
was evaporated under reduced pressure and the residue
purified by column chromatography (PE–EtOAc, 20:1) to
give spiroindanone δ-lactone 7.
References and Notes
(1) (a) Duarte, C. D.; Barreiro, E. J.; Fraga, C. A. Mini-Rev.
Med. Chem. 2007, 7, 1108. (b) Lowe, J. A.; Hageman, D. L.;
Drozda, S. E.; McLean, S.; Bryce, D. K.; Crawford, R. T.;
Zorn, S.; Morrone, J.; Bordner, J. J. Med. Chem. 1994, 37,
3789. (c) Clark, W. M.; Tickner-Eldridge, A. M.; Huang, G.
K.; Pridgen, L. N.; Olsen, M. A.; Mills, R. J.; Lantos, I.;
Baine, N. H. J. Am. Chem. Soc. 1998, 120, 4550.
(2) (a) Kim, S.-H.; Kwon, S. H.; Park, S.-H.; Lee, J. K.; Bang,
H.-S.; Nam, S.-J.; Kwon, H. C.; Shin, J.; Oh, D.-C. Org. Lett.
2013, 15, 1834. (b) Uddin, S. J.; Jason, T. L. H.; Beattie, K.
D.; Grice, I. D.; Tiralongo, E. J. Nat. Prod. 2011, 74, 2010.
(c) Ito, T.; Tanaka, T.; Linuma, M.; Nakaya, K.; Takahashi,
Y.; Sawa, R.; Murata, J.; Darnaedi, D. J. Nat. Prod. 2004,
67, 932. (d) Pizzirani, D.; Roberti, M.; Grimaudo, S.;
Cristina, A. D.; Pipitone, R. M.; Tolomeo, M.; Recanatini,
M. J. Med. Chem. 2009, 52, 6936.
(3) (a) Yavari, I.; Mirzaei, A.; Moradi, L.; Hosseini, N.
Tetrahedron Lett. 2008, 49, 2355. (b) Nair, V.; Devipriya,
S.; Suresh, E. Synthesis 2008, 1065.
(4) Li, M.; Yang, W.-L.; Wen, L.-R.; Li, F.-Q. Eur. J. Org.
Chem. 2008, 2751.
(5) Sternativo, S.; Calandriello, A.; Costantino, F.; Testaferri,
L.; Tiecco, M.; Marini, F. Angew. Chem. Int. Ed. 2011, 50,
9382.
(6) Ramachary, D. B.; Venkaiah, C.; Krishna, P. M. Chem.
Commun. 2012, 48, 2252.
(7) For the diastereoselective synthesis of oxa-spirocyclic
indanones, see: Lehmler, H.-J.; Nieger, M.; Breitmaier, E.
Synthesis 1996, 105.
(8) (a) Nicolaou, K. C.; Edmonds, D. J.; Bulger, P. G. Angew.
Chem. Int. Ed. 2006, 45, 7134. (b) Enders, D.; Grondal, C.;
Hüttl, M. R. M. Angew. Chem. Int. Ed. 2007, 46, 1570.
(c) Grondal, C.; Jeanty, M.; Enders, D. Nat. Chem. 2010, 2,
167.
(9) (a) Betancort, J. M.; Barbas, C. F. III. Org. Lett. 2001, 3,
3737. (b) Alexakis, A.; Andrey, O. Org. Lett. 2002, 4, 3611.
(c) Berner, O. M.; Tedeschi, L.; Enders, D. Eur. J. Org.
Chem. 2002, 1877. (d) List, B. Tetrahedron 2002, 58, 5573.
(e) Hayashi, Y.; Gotoh, H.; Hayashi, T.; Shoji, M. Angew.
Chem. Int. Ed. 2005, 44, 4212. (f) Sulzer-Mossé, S.;
Alexakis, A. Chem. Commun. 2007, 3123. (g) Tsogoeva, S.
B. Eur. J. Org. Chem. 2007, 1701.
Oxa-spirocyclic indanone 7a was obtained as a white solid
in 70% yield over the two steps after flash chromatography.
The enantiomeric excess was determined to be 93% by
HPLC on a Chiralpak OD-H column (i-PrOH–n-hexane,
3:7, 1 mL/min); UV (254 nm), tminor = 11.05 min,
tmajor = 12.11 min; mp 167–168 °C; [α]D20 –129.4 (c 0.12,
CH2Cl2). 1H NMR (400 MHz, CDCl3): δ = 8.12–8.05 (m, 2
H), 8.01–7.94 (m, 2 H), 7.40–7.34 (m, 3 H), 7.27–7.26 (m, 2
H), 5.64 (d, J = 12.4 Hz, 1 H), 4.16 (t, J = 12.0 Hz, 1 H),
3.10–3.02 (m, 1 H), 1.39 (d, J = 6.8 Hz, 3 H). 13C NMR (100
MHz, CDCl3): δ = 192.31, 190.03, 169.62, 141.15, 140.18,
138.00, 137.48, 135.43, 129.51, 129.05, 127.77, 124.99,
124.72, 87.28, 46.58, 41.42, 14.74. HRMS (ESI): m/z [M +
H]+ calcd for C20H15NO6Na: 388.0797; found: 388.0795.
(15) For a comprehensive review on dienamine catalysis, see:
Ramachary, D. B.; Reddy, Y. V. Eur. J. Org. Chem. 2012,
865.
(16) CCDC 919807 contains the supplementary crystallographic
data for the structure in this paper. The data can be obtained
free of charge from The Cambridge Crystallographic Data
(17) Bedford, S. B.; Bell, K. E.; Bennett, F.; Hayes, C. J.; Knight,
D. W.; Shaw, D. E. J. Chem. Soc., Perkin Trans. 1 1999,
2143.
(18) The hexahydrofuro[2,3-b]pyran derivativesare synthetically
useful building blocks. For selected examples, see:
(a) Drewes, S. E.; Horn, M. M.; Munro, O. Q.; Ramesar, N.;
Ochse, M.; Bringmann, G.; Peters, K.; Peters, E.-M.
Phytochemistry 1999, 50, 387. (b) Chen, X.-Z.; Wu, H.-F.;
Li, G.-Y.; Lu, S.-M.; Li, B.-G.; Fang, D.-M.; Zhang, G.-L.
Helv. Chim. Acta 2008, 91, 1072.
(10) (a) Enders, D.; Hüttl, M. R. M.; Grondal, C.; Raabe, G.
Nature 2006, 441, 861. (b) Enders, D.; Hüttl, M. R. M.;
© Georg Thieme Verlag Stuttgart · New York
Synlett 2014, 25, 143–147